Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
11/2008
11/05/2008CN101300005A N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
11/05/2008CN101297864A Preparation of Xia sang ju formulation
11/05/2008CN101297824A Preparation of sustained-release medical membrane
11/04/2008US7446105 4-(1,2-diethyl-4-methylimidazol-5-yl)-2-{4-[N-(2-methoxyethyl)sulphamoyl]anilino}pyrimidine; selectivity for cyclin-dependent serine/threonine kinases (CDK2, CDK4 and CDK6); antiproliferative agent; minimize pharma toxicity on S-phase cell cycle, G2 or mitosis; oncogene signalling pathways
11/04/2008US7446097 Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy
11/04/2008US7445777 Enzymatic treatment of retinitis pigmentosis
11/04/2008CA2430470C Novel use of a peptide class of compound for treating allodynia or other different types of chronic or phantom pain
10/2008
10/30/2008WO2008131439A1 Treatment and/or prevention of presbycusis by modulation of metabotropic glutamate receptor 7
10/30/2008WO2008130951A1 Fused heterocyclic 11-beta-hydroxysteroid dehydrogenase type i inhibitors
10/30/2008WO2008130647A1 Copolymer synthesized from modified glycosaminoglycan, gag, and an anhydride functionalized hydrophobic polymer
10/30/2008WO2008130332A1 Subsituted sulphonamides, process for their preparation, pharmaceutical composition comprising thereof and their use
10/30/2008WO2008129129A1 Heterocyclic phenyl carbamates as novel faah-inhibitors
10/30/2008US20080269349 administering an isolated astaxanthin and a mono- or di-ester thereof; controlling cytokine or TGF- alpha -related gene expression; reducing muscle atrophy, treating diabetes
10/30/2008US20080269324 long chain retinyl ketone, ester, amide, retinimide etc. free of N-(4-hydroxyphenyl)retinamide); inhibits, antagonizes, or short-circuits the visual cycle at a step of the visual cycle that occurs outside a disc of a rod photoreceptor
10/30/2008US20080269318 Treatment of age-related macular degeneration using inhibitors of complement factor d
10/30/2008US20080269295 Substituted thiazoles and their use for producing drugs
10/30/2008US20080269282 Including semicarbazide-sensitive amine oxidase (vascular adhesion protein-1, VAP-I), and therapeutic use in inflammatory diseases, diabetes and its associated complications, atherosclerosis, neurodegenerative diseases, obesity, hypertension and cancer; N1-hydroxy-N2-[(4-bromophenyl)carbonyl]glycinamide
10/30/2008US20080269260 Using a purine compound; antiallergens; antiinflammatory agents; cognition activators; drug abuse; schizophenia; Alzheimer's disease; Parkinson's disease
10/30/2008US20080269257 Use of Substituted 2-Pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-A] Pyrimidin-4-one and 7-Pyrimidinyl-2,3-dihydroimidazo[1,2-A] Pyrimidin-5(1H)one Derivatives
10/30/2008US20080269254 Antiproliferative agents; anticancer agents; graft versus host disease; rheumatic diseases; vision defects; cardiovascular disorders
10/30/2008US20080269187 Applying propylene glycol to ear with antibiotic, viricides, fungicide, antiinflammatory agents
10/30/2008US20080269181 Methods for treating a posterior segment of an eye
10/30/2008US20080269156 Antisense strand, sense strand are non-phosphorylated at the 5' and 3' termini; pulmonary, eye, microvascular, hearing disorders; target for hypoxia-inducible factor-1 that may regulate hypoxia-induced pathogenesis independent of growth factors such as VEGF
10/30/2008US20080269129 Polypeptide and dna thereof useful as a neovascular marker
10/30/2008US20080269128 Albumin Fusion Proteins
10/30/2008US20080269127 Albumin Fusion Proteins
10/30/2008US20080269126 Albumin Fusion Proteins
10/30/2008US20080269125 Albumin Fusion Proteins
10/30/2008US20080269120 Biodrugs comprising polypeptides and carriers comprising bioadhesives such as fibrin, for treatment of vision defects; chimeric C3-like Rho antagonists and their use for promoting repair and neuron survival in injured mammalian central and peripheral nervous system and for treating cancer
10/30/2008US20080269119 Ophthalmic Device and Related Methods and Compositions
10/30/2008US20080268051 Anti-angiogenesis; viscosity inducing component is injectable into the vitreous of a mammalian eye without permanently diminishing visual acuity
10/30/2008US20080268033 Biologically active methylene blue derivatives
10/30/2008US20080268020 Ophthalmic Emulsions Containing Prostaglandins
10/30/2008US20080267962 Albumin Fusion Proteins
10/30/2008US20080267946 Using transforming growth factor specific immunglobulin as therapeutic in treatment of hereditary vision defect
10/30/2008US20080267929 Use of stem cells to generate inner ear cells
10/30/2008CA2684591A1 Subsituted sulphonamides, process for their preparation, pharmaceutical composition comprising thereof and their use
10/29/2008EP1986011A2 Peptide epitopes recognized by disease promoting CD4+ T lymphocytes
10/29/2008EP1985632A2 Use of VEGF2 antibodies for inhibiting photoreceptor cell proliferation
10/29/2008EP1984003A2 Therapeutic uses of inhibitors of rtp801
10/29/2008EP1809238B1 Ophthalmic emulsions containing an immunosuppressive agent
10/29/2008EP1406650B1 Use of poly-glu, tyr for neuroprotection therapy of the cns or pns
10/29/2008CN101296706A Use of IL-23 and IL-17 antagonists to treat autoimmune ocular inflammatory disease
10/29/2008CN101293056A Medicament for preventing and treating near-sightedness
10/29/2008CN101293038A Gallbladder leaves extract, preparing method, its preparation and uses
10/29/2008CN101293034A Medicament composition for treating otitis medium and preparation thereof
10/29/2008CN101292741A Health care bamboo salt with mind pacifying and digestion promoting function, and method of preparing the same
10/29/2008CN100429232C Vaughan Tristan J.
10/29/2008CN100429201C Heterocyclic compounds and methods of use thereof
10/29/2008CN100428966C Nasal delivery devices
10/29/2008CN100428958C Implant agent for treating ophthalmopathy
10/28/2008US7442837 Phenethanolamine derivatives for treatment of respiratory diseases
10/28/2008US7442836 Phenethanolamine derivatives for treatment of respiratory diseases
10/28/2008US7442790 Caspase inhibitors and uses thereof
10/28/2008US7442719 Methods using phenethanolamine derivatives for treatment of respiratory diseases
10/28/2008US7442715 Thiazole derivatives
10/28/2008US7442711 Amelioration of the development of cataracts and other ophthalmic diseases
10/28/2008US7442708 Inhibitors of basic fibroblast growth factors (FGFs); treating cancer, rheumatoid arthritis, inflammatory bowel disease, cardiovascular disorders, diabetic retinopathy, achondroplasia, hypochondoplasia, or thanathophoric dysplasia
10/28/2008US7442702 Prostaglandin agonists
10/28/2008US7442699 For treatment of rheumatoid arthritis, inflammatory or autoimmune condition, viral infection, cancer; 4-{[4-(4-chlorophenyl)pyrimidin-2-yl]amino}benzamide
10/28/2008US7442688 Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation
10/28/2008CA2403152C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
10/28/2008CA2315767C Autoclavable pharmaceutical compositions containing a chelating agent
10/28/2008CA2275167C The topical use of kappa opioid agonists to treat ocular pain
10/23/2008WO2008127727A1 Biaryl compositions and methods for modulating a kinase cascade
10/23/2008WO2008127715A1 Carboline derivatives useful in the treatment of cancer and other diseases
10/23/2008WO2008126920A1 Remedy for diabetes
10/23/2008WO2008126886A1 Indole or indoline derivative
10/23/2008WO2008126803A1 Ophthalmic composition comprising soluble, cross-linked hyaluronic acid
10/23/2008WO2008126732A1 Fused bicyclic heteroaryl derivatives
10/23/2008WO2008126720A1 Suspension for visualization of transparent tissue in eye
10/23/2008WO2008124940A1 Use of cyclohexanehexol derivatives in the treatment of ocular diseases
10/23/2008WO2008100463B1 3,4-dihydr0-l,4-benz0xazine, 3, 4-dihydr0-1, 4-benzothiazine and 1,2,3,4-tetrahydro-quinoxaline derivatives as alpha2c adrenoreceptor agonists
10/23/2008US20080262087 Modified g-protein coupled receptor for identifying modulators of taste preception; artificial sweeteners
10/23/2008US20080262045 N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}-4-(4-fluorophenoxy)benzenesulfonamide and N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}[1,1'-biphenyl]-4-sulfonamide; chemical intermediates for enzyme inhibitors; especially as inhibitors of MMP12
10/23/2008US20080262016 Isoquinoline derivatives and methods of use thereof
10/23/2008US20080261976 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
10/23/2008US20080261961 Kinase inhibitors useful for the treatment of myleoprolific diseases and other proliferative diseases
10/23/2008US20080261960 Photosensitizers for photodynamic therapy; killing tissue, cells; anticancer agents
10/23/2008US20080261947 Poly(ADP-ribose)polymerase inhibitor; ischemic diseases, cerebral infarction, antiretroviral, sensitizer for anticancer therapy, immunosuppressant; 5,6,7,8-tetrahydrophthalazin-1(2H)-one compounds; 2,3,4,6-tetrahydropyrido[2,3-d]pyridazin-5(1H)-one compounds
10/23/2008US20080261943 Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use
10/23/2008US20080261893 Contains neo-tryptophan; transdermal patches
10/23/2008US20080261890 Use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions
10/23/2008US20080261877 Albumin Fusion Proteins
10/23/2008US20080261867 Soluble inhibitors of vascular endothelial growth factor and use thereof
10/23/2008US20080260859 Dietary supplement to treat dry eye condition; fish oil triglycerides, eicosapentaenoic acid, docosahexaenoic acid, gamma-linolenic acid, zinc sulphate, vitamin E, vitamin C, vitamin B6, vitamin B12; solid, liquid, or gel; glycerol monostearate, lecithin, gelatin
10/23/2008US20080260832 Sustained release intraocular implants and methods for preventing retinal dysfunction
10/23/2008US20080260759 Novel Mite Allergen
10/23/2008US20080260747 Adhesion interaction protein (CD-84) specific immunoglobulin for use in the treatment of cell proliferative disorders of the blood
10/23/2008US20080260702 Using vector comprising nucleotide sequences coding neublastin as therapeutic treatment for vision defects
10/23/2008CA2683607A1 Use of cyclohexanehexol derivatives in the treatment of ocular diseases
10/23/2008CA2683089A1 Benzimidazole derivatives and imidazopyridine derivatives with glucose lowering effect
10/23/2008CA2682730A1 Use of an inhibitor of tnf.alpha. plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis
10/23/2008CA2682378A1 Suspension for visualization of transparent tissue in eye
10/22/2008EP1983055A1 Albumin fusion proteins
10/22/2008EP1982701A2 Sustained Release Drug Delivery Devices, Methods of Use, and Methods of Manufacturing Thereof
10/22/2008EP1982559A2 Composition and method of treating hearing loss
10/22/2008EP1981491A2 Formulations and methods for treating dry eye
10/22/2008EP1472257B1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
10/22/2008EP1318983B1 Substituted imidazoles as histamine h1 and h3 agonists or antagonists
1 ... 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 ... 531